Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.

作者: Iris Gehrke , Rajesh Kumar Gandhirajan , Simon Jonas Poll-Wolbeck , Michael Hallek , Karl-Anton Kreuzer

DOI: 10.2119/MOLMED.2010.00210

关键词:

摘要: Chronic lymphocytic leukemia (CLL) cells feature a pronounced apoptotic resistance. The vascular endothelial growth factor (VEGF) possesses role in this block, although underlying functional mechanisms and the involvement of microenvironment are unclear. In study, VEGF status CLL was assessed by enzyme-linked immunosorbent assay immunofluorescence. receptor 2 (VEGFR2) phosphorylation determined flow cytometrically For co-culture, were cultivated on monolayer bone marrow-derived stromal cell (BMSC) line HS5. Secreted neutralized using monoclonal antibody mAb293 (R&D Systems, Minneapolis, MN, USA). To block protein secretion, we used Brefeldin A. downregulated BMSCs small interfering RNA (siRNA), survival annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) staining. express secrete possess phosphorylated VEGFR2. This positive is not sufficient to prevent spontaneous apoptosis vitro. Coculture with BMSCs, which vast amounts VEGF, maintains vitro survival. Blockage secreted significantly reduced support for cocultured cells. Both general blockage secretion A but cells, siRNA-mediated downregulation coculture-mediated It can be concluded that BMSC-derived proteins particular, cell-derived essentially involved Hence, therapeutic targeting signaling might promising approach overcome resistance within their natural microenvironment.

参考文章(33)
Paolo Ghia, Federico Caligaris-Cappio, The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms Advances in Cancer Research. ,vol. 79, pp. 157- 173 ,(2000) , 10.1016/S0065-230X(00)79005-1
Keating Mj, Chronic lymphocytic leukemia. Seminars in Oncology. ,vol. 26, pp. 107- 114 ,(1999)
Jerzy Z Blonski, Tadeusz Robak, Joanna Gora-Tybor, Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia. European Cytokine Network. ,vol. 16, pp. 41- 46 ,(2005)
Taghi Manshouri, Alessandra Ferrajoli, Zeev Estrov, Hagop M. Kantarjian, Susan O’Brien, Susan Lerner, Emil J. Freireich, Maher Albitar, Miloslav Beran, Michael J. Keating, High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia Clinical Cancer Research. ,vol. 7, pp. 795- 799 ,(2001)
Irene Munk Pedersen, John Reed, Microenvironmental interactions and survival of CLL B-cells. Leukemia & Lymphoma. ,vol. 45, pp. 2365- 2372 ,(2004) , 10.1080/10428190412331272703
P. Panayiotidis, D. Jones, K. Ganeshaguru, L. Foroni, A. V. Hoffbrand, Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro British Journal of Haematology. ,vol. 92, pp. 97- 103 ,(1996) , 10.1046/J.1365-2141.1996.00305.X
Yean K. Lee, Nancy D. Bone, Ann K. Strege, Tait D. Shanafelt, Diane F. Jelinek, Neil E. Kay, VEGF Receptor Phosphorylation Status and Apoptosis is Modulated by a Green Tea Component, Epigallocatechin-3-gallate (EGCG) in B cell Chronic Lymphocytic Leukemia Blood. ,vol. 104, pp. 788- 794 ,(2004) , 10.1182/BLOOD-2003-08-2763